Byoung S. Kwon

Byoung S. Kwon

Dr. Kwon had his PhD from the Georgia Regents University in the USA and postdoctoral studies at the Department of Human Genetics, Yale University, School of Medicine. Dr. Kwon was a tenured Professor of the Indiana University School of Medicine, a Professor and Director of the Immunomodulation Research Center at the University of Ulsan, a Distinguished Professor and Investigator at the National Cancer Center, Korea, and Professor at the Department of Medicine Tulane University, New Orleans LA. He is currently the Founder and CEO of Eutilex who is developing T cell therapeutics and immunomodulatory antibody therapeutics. He has published over 300 peer-reviewed papers and has been serving as an editorial member of reputable journals.

Are you ready?

Get Early Access to
BioCon Asia-ACGT Conference!